Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
NCT04297592Phase 4Enrolling by invitation
- Sponsor
- Mayo Clinic
- Start
- Jun 2020
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefalexin, doxycycline and cefadroxil in periprosthetic joint infection (PJI) and Postoperative wound complications (2 arms), sponsored by Mayo Clinic. Primary endpoint: Periprosthetic joint infections at 1 year. Started Jun 2020; status: enrolling by invitation.
02
Drugs
cefalexindoxycyclinecefadroxil
03
Conditions
periprosthetic joint infection (PJI)Postoperative wound complications
Beyond the preview
Go deeper on NCT04297592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04297592.